Melanie M Bryan1, Nathanial J Tolman1, Karen L Simon1, Marjan Huizing1, Robert B Hufnagel2, Brian P Brooks2, Vladislav Speransky3, James C Mullikin4, William A Gahl5, May Christine V Malicdan6, Bernadette R Gochuico1. 1. Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA. 2. Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA. 3. National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA. 4. NIH Intramural Sequencing Center, National Institutes of Health, 5625 Fishers Lane, Rockville, MD 20852, USA. 5. Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA; Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA; NIH Undiagnosed Diseases Program, Common Fund, Office of the Director, 9000 Rockville Pike, National Institutes of Health, Bethesda, MD 20892, USA. 6. NIH Undiagnosed Diseases Program, Common Fund, Office of the Director, 9000 Rockville Pike, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: maychristine.malicdan@nih.gov.
Abstract
PURPOSE: Hermansky-Pudlak syndrome (HPS) is a rare inherited disorder with ten reported genetic types; each type has defects in subunits of either Adaptor Protein-3 complex or Biogenesis of Lysosome-related Organelles Complex (BLOC)-1, -2, or -3. Very few patients with BLOC-1 deficiency (HPS-7, -8, and -9 types) have been diagnosed. We report results of comprehensive clinical testing and molecular analyses of primary fibroblasts from a new case of HPS-7. RESULTS: A 6-year old Paraguayan male presented with hypopigmentation, ocular albinism, nystagmus, reduced visual acuity, and easy bruising. He also experienced delayed motor and language development as a very young child; head and chest trauma resulted in intracranial hemorrhage with subsequent right hemiparesis and lung scarring. There was no clinical evidence of immunodeficiency or colitis. Whole mount transmission electron microscopy revealed absent platelet delta granules; platelet aggregation testing was abnormal. Exome sequencing revealed a homozygous nonsense mutation in the Dystrobrevin binding protein 1 (DTNBP1) gene [NM_032122.4: c.307C>T; p.Gln103*], previously reported in a Portuguese adult. The gene encodes the dysbindin subunit of BLOC-1. Dysbindin protein expression was negligible in our patient's dermal fibroblasts, while his DTNBP1 mRNA level was similar to that of a normal control. CONCLUSIONS: Comprehensive clinical evaluation of the first pediatric case reported with HPS-7 reveals oculocutaneous albinism and platelet storage pool deficiency; his phenotype is consistent with findings in other patients with BLOC-1 disorders. This patient's markedly reduced Dysbindin protein expression in HPS-7 resulted from a mechanism other than nonsense mediated decay. Published by Elsevier Inc.
PURPOSE:Hermansky-Pudlak syndrome (HPS) is a rare inherited disorder with ten reported genetic types; each type has defects in subunits of either Adaptor Protein-3 complex or Biogenesis of Lysosome-related Organelles Complex (BLOC)-1, -2, or -3. Very few patients with BLOC-1 deficiency (HPS-7, -8, and -9 types) have been diagnosed. We report results of comprehensive clinical testing and molecular analyses of primary fibroblasts from a new case of HPS-7. RESULTS: A 6-year old Paraguayan male presented with hypopigmentation, ocular albinism, nystagmus, reduced visual acuity, and easy bruising. He also experienced delayed motor and language development as a very young child; head and chest trauma resulted in intracranial hemorrhage with subsequent right hemiparesis and lung scarring. There was no clinical evidence of immunodeficiency or colitis. Whole mount transmission electron microscopy revealed absent platelet delta granules; platelet aggregation testing was abnormal. Exome sequencing revealed a homozygous nonsense mutation in the Dystrobrevin binding protein 1 (DTNBP1) gene [NM_032122.4: c.307C>T; p.Gln103*], previously reported in a Portuguese adult. The gene encodes the dysbindin subunit of BLOC-1. Dysbindin protein expression was negligible in our patient's dermal fibroblasts, while his DTNBP1 mRNA level was similar to that of a normal control. CONCLUSIONS: Comprehensive clinical evaluation of the first pediatric case reported with HPS-7 reveals oculocutaneous albinism and platelet storage pool deficiency; his phenotype is consistent with findings in other patients with BLOC-1 disorders. This patient's markedly reduced Dysbindin protein expression in HPS-7 resulted from a mechanism other than nonsense mediated decay. Published by Elsevier Inc.
Entities:
Keywords:
Biogenesis of Lysosome-related Organelles Complex-1; DTNBP1; Dysbindin; Oculocutaneous albinism; Platelet storage pool disorder
Authors: Raffaele Badolato; Alberto Prandini; Sonia Caracciolo; Francesca Colombo; Giovanna Tabellini; Mauro Giacomelli; Maria E Cantarini; Andrea Pession; Callum J Bell; Darrell L Dinwiddie; Neil A Miller; Shannon L Hateley; Carol J Saunders; Lu Zhang; Gary P Schroth; Alessandro Plebani; Silvia Parolini; Stephen F Kingsmore Journal: Blood Date: 2012-03-29 Impact factor: 22.113
Authors: Bernadette R Gochuico; Marjan Huizing; Gretchen A Golas; Charles D Scher; Maria Tsokos; Stacey D Denver; Melissa J Frei-Jones; William A Gahl Journal: Mol Med Date: 2012-02-10 Impact factor: 6.354
Authors: Marjan Huizing; Charles D Scher; Erin Strovel; Diana L Fitzpatrick; Lisa M Hartnell; Yair Anikster; William A Gahl Journal: Pediatr Res Date: 2002-02 Impact factor: 3.756
Authors: Neil V Morgan; Shanaz Pasha; Colin A Johnson; John R Ainsworth; Robin A J Eady; Ban Dawood; Carole McKeown; Richard C Trembath; Jonathan Wilde; Steve P Watson; Eamonn R Maher Journal: Am J Hum Genet Date: 2005-11-28 Impact factor: 11.025
Authors: Tamio Suzuki; Wei Li; Qing Zhang; Amna Karim; Edward K Novak; Elena V Sviderskaya; Simon P Hill; Dorothy C Bennett; Alex V Levin; H Karel Nieuwenhuis; Chin-To Fong; Claudio Castellan; Bianca Miterski; Richard T Swank; Richard A Spritz Journal: Nat Genet Date: 2002-02-11 Impact factor: 38.330
Authors: Sairah Yousaf; Mohsin Shahzad; Tasleem Kausar; Shakeel A Sheikh; Nabeela Tariq; Asra S Shabbir; Muhammad Ali; Ali M Waryah; Rehan S Shaikh; Saima Riazuddin; Zubair M Ahmed Journal: Pigment Cell Melanoma Res Date: 2015-12-18 Impact factor: 4.693
Authors: Carmelo Carmona-Rivera; Dimitre R Simeonov; Nicholas D Cardillo; William A Gahl; Carmen L Cadilla Journal: Biochim Biophys Acta Date: 2012-10-23
Authors: Gillian C Lowe; Isabel Sánchez Guiu; Oliver Chapman; José Rivera; Marie Lordkipanidzé; Natalia Dovlatova; Jonathan Wilde; Steve P Watson; Neil V Morgan Journal: Thromb Haemost Date: 2013-01-31 Impact factor: 5.249
Authors: Jose María Bastida; Sara Morais; Veronica Palma-Barqueros; Rocio Benito; Nuria Bermejo; Mutlu Karkucak; Maria Trapero-Marugan; Natalia Bohdan; Mónica Pereira; Ana Marin-Quilez; Jorge Oliveira; Yusuf Yucel; Rosario Santos; Jose Padilla; Kamila Janusz; Catarina Lau; Marta Martin-Izquierdo; Eduarda Couto; Juan Francisco Ruiz-Pividal; Vicente Vicente; Jesus Maria Hernández-Rivas; Jose Ramon González-Porras; Maria Luisa Lozano; Margarida Lima; Jose Rivera Journal: Ann Med Date: 2019-04-16 Impact factor: 4.709
Authors: Cortnie Hartwig; William J Monis; Xun Chen; Dion K Dickman; Gregory J Pazour; Victor Faundez Journal: Dev Neurobiol Date: 2017-10-13 Impact factor: 3.964
Authors: Bernadette R Gochuico; Shira G Ziegler; Nicholas S Ten; Nicholas J Balanda; Christopher E Mason; Paul Zumbo; Colleen A Evans; Carter Van Waes; William A Gahl; May C V Malicdan Journal: Transl Res Date: 2019-08-28 Impact factor: 7.012
Authors: Chen G Han; Kevin J O'Brien; Lea M Coon; Julie A Majerus; Laryssa A Huryn; Sara G Haroutunian; Nagabhishek Moka; Wendy J Introne; Ellen Macnamara; William A Gahl; May Christine V Malicdan; Dong Chen; Koyamangalath Krishnan; Bernadette R Gochuico Journal: Am J Med Genet A Date: 2018-10-04 Impact factor: 2.802
Authors: Frank Y Lee; Jennifer Larimore; Victor Faundez; Esteban C Dell'Angelica; Cristina A Ghiani Journal: J Neurosci Res Date: 2020-05-20 Impact factor: 4.433
Authors: Frank Y Lee; Huei-Bin Wang; Olivia N Hitchcock; Dawn Hsiao Loh; Daniel S Whittaker; Yoon-Sik Kim; Achilles Aiken; Collette Kokikian; Esteban C Dell'Angelica; Christopher S Colwell; Cristina A Ghiani Journal: Front Neurosci Date: 2018-11-15 Impact factor: 4.677
Authors: Marjan Huizing; May C V Malicdan; Jennifer A Wang; Hadass Pri-Chen; Richard A Hess; Roxanne Fischer; Kevin J O'Brien; Melissa A Merideth; William A Gahl; Bernadette R Gochuico Journal: Hum Mutat Date: 2020-01-23 Impact factor: 4.700
Authors: Bret A Moore; Ann M Flenniken; Dave Clary; Ata S Moshiri; Lauryl M J Nutter; Zorana Berberovic; Celeste Owen; Susan Newbigging; Hibret Adissu; Mohammad Eskandarian; Colin McKerlie; Sara M Thomasy; K C Kent Lloyd; Christopher J Murphy; Ala Moshiri Journal: Sci Rep Date: 2019-08-01 Impact factor: 4.379